Gland Pharma Ltd GLAND
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 1,738.60
- Day Range
- INR 1,722.00–1,756.70
- 52-Week Range
- INR 861.00–2,194.00
- Bid/Ask
- INR 1,728.35 / INR 1,728.35
- Market Cap
- INR 284.68 Bil
- Volume/Avg
- 166,537 / 520,365
Key Statistics
- Price/Earnings (Normalized)
- 40.72
- Price/Sales
- 5.83
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Further, the group is involved in vast range of therapeutic categories that include Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarial, Cardiology and more - to Hormones and related Drugs, Fertility Supplements and Gnrh Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 4,585
- Website
- https://www.glandpharma.com
Comparables
Valuation
|
Metric
|
GLAND
|
509079
|
500288
|
|---|---|---|---|
Price/Earnings (Normalized) | 40.72 | 37.16 | 33.99 |
Price/Book Value | 3.43 | 7.95 | 3.30 |
Price/Sales | 5.83 | 3.99 | 1.58 |
Price/Cash Flow | 34.51 | 29.58 | 32.23 |
Price/Earnings
GLAND
509079
500288
Financial Strength
|
Metric
|
GLAND
|
509079
|
500288
|
|---|---|---|---|
Quick Ratio | 2.35 | 0.74 | 0.95 |
Current Ratio | 3.89 | 1.35 | 2.23 |
Interest Coverage | 45.32 | 8.37 | 30.56 |
Quick Ratio
GLAND
509079
500288
Profitability
|
Metric
|
GLAND
|
509079
|
500288
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
GLAND
509079
500288
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Scvyfkphk | Dcld | $697.4 Bil | |
JNJ
| Johnson & Johnson | Rwmzxkzyt | Gss | $353.8 Bil | |
MRK
| Merck & Co Inc | Jjtdbts | Cmpz | $332.3 Bil | |
ABBV
| AbbVie Inc | Gfpdkqyxj | Slz | $282.6 Bil | |
AZN
| AstraZeneca PLC ADR | Tvgltzcr | Sxwl | $232.3 Bil | |
NVS
| Novartis AG ADR | Lykclyr | Cvdl | $200.1 Bil | |
RHHBY
| Roche Holding AG ADR | Vcdcztgqks | Rmw | $195.3 Bil | |
AMGN
| Amgen Inc | Wjvnvkybvj | Zdm | $144.5 Bil | |
PFE
| Pfizer Inc | Dgmpxdl | Tydgs | $143.8 Bil | |
SNY
| Sanofi SA ADR | Dlbzchjsw | Bpj | $122.2 Bil |